Thermo Fisher Scientific settles with family of Henrietta Lacks, whose HeLa cells uphold medicine
The family of Henrietta Lacks is settling a lawsuit against a biotechnology company it accuses of improperly profiting from her cells
BALTIMORE (AP) — More than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical cells without her knowledge, a lawyer for her descendants said they have reached a settlement with a biotechnology company they sued in 2021, accusing its leaders of reaping billions of dollars from a racist medical system.
Tissue taken from the Black woman’s tumor before she died of cervical cancer became the first human cells to be successfully cloned. Reproduced infinitely ever since, HeLa cells have become a cornerstone of modern medicine, enabling countless scientific and medical innovations, including the development of the polio vaccine, genetic mapping and even COVID-19 vaccines.
Despite that incalculable impact, the Lacks family had never been compensated.
Doctors harvested Lacks’ cells in 1951, long before the advent of consent procedures used in medicine and scientific research today, but lawyers for her family argued that Thermo Fisher Scientific Inc., of Waltham, Massachusetts, has continued to commercialize the results well after the origins of the HeLa cell line became well known.
